Why the study?
Are glucose-related variables (ARPG, GVT, HbA1c) associated with plaque rupture and vulnerable plaque morphology in patients with STEMI?
Are glucose-related variables (ARPG, GVT, HbA1c) associated with plaque rupture and vulnerable plaque morphology in patients with STEMI?
Admission random plasma glucose and glucose variability are significant risk factors for plaque rupture and vulnerable plaque morphology in STEMI patients, highlighting the importance of acute glycemic status even in non-diabetics.
Answers are grounded in this paper and cite their sources.
May support glycemic monitoring in nondiabetic STEMI; leaves open whether targeting ARPG or GVT improves plaque stability or outcomes.
Compared to HbA1c, DM history, and some other glucose-related variables, ARPG and GVT were risk factors for PR in STEMI patients, especially those without DM. And high HbA1c and ARPG were positively correlated with the development of vulnerable plaque in culprit vessels. Trial registration Present study is a retrospective one and the population came from the EROSION study of our center previously. It was approved by the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University (Approval reference number, KY2017-249), and all patients provided written informed consent prior to the inclusion in the study and the investigation conformed to the principles outlined in the Declaration of Helsinki.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: